SAMN33843034
External Id
dbGaP
INSDC center name
2023-03-21T12:19:22.227Z
INSDC first public
2023-07-14T03:18:31.903Z
INSDC last update
SRS17620072
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS17620072
SRA accession
DNA
analyte type
NCI_PALTAN
biospecimen repository
M1519622_1
biospecimen repository sample id
blood
body site
phs003147
gap_accession
1
gap_consent_code
GRU-PUB
gap_consent_short_name
5344741
gap_sample_id
4420252
gap_subject_id
blood
histological type
No
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
female
sex
Clinical Trial
study design
A Phase II Neoadjuvant Study of Palbociclib in Combination with Letrozole and Trastuzumab as Neoadjuvant Treatment of Stage II-III ER+ HER2+ Breast Cancer (PALTAN)
study name
M1519622_1
submitted sample id
MANTAN003
submitted subject id
NCI_PALTAN
submitter handle
Non-tumor DNA sample from blood of a human female participant in the dbGaP study A Phase II Neoadjuvant Study of Palbociclib in Combination with Letrozole and Trastuzumab as Neoadjuvant Treatment of Stage II-III ER+ HER2+ Breast Cancer (PALTAN)
title